Arizona confirms first state case of Clade I mpox linked to travel
The Arizona Department of Health Services has confirmed the state's first case of Clade I mpox, identified in a resident following international travel.
Case Identification and Details
Public health authorities in Arizona were notified this month of a resident who contracted the Clade I mpox virus. This specific strain represents a different lineage than the Clade II virus responsible for the 2022 global outbreak.
Health officials have confirmed the infection is travel-associated, meaning the individual likely contracted the virus outside of the United States. The Arizona Department of Health Services (ADHS) is currently managing the case and monitoring for any potential local transmission.
Understanding Clade I mpox
Mpox is a viral zoonotic disease that can spread through close contact with infected persons, contaminated materials, or animals. While many people experience mild symptoms, Clade I has historically been associated with more severe clinical outcomes in certain regions of Africa.
Key distinctions between the strains include:
- Clade I: Historically linked to more severe outbreaks and higher mortality rates in specific geographical clusters.
- Clade II: The strain responsible for the widespread multi-country outbreak observed globally in 2022.
Public Health Response
The ADHS is working alongside federal health agencies to conduct contact tracing and ensure the resident receives appropriate medical care. Health officials are assessing whether further preventative measures or public health alerts are necessary for the local community.
Residents are advised to monitor for symptoms, which typically include:
- Fever and chills
- Swollen lymph nodes
- Rash or lesions on the skin
- Muscle aches and exhaustion
Health authorities continue to urge travelers returning from regions with active mpox outbreaks to remain vigilant and seek medical consultation if they display unexpected symptoms.
